Back to Rankings

INVA

InnovivaC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
INVA vs peer average
47/100
INVA vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CAPR is the first available peer comparator.

Same-sector small-cap biopharma comp that is closer in market-cap scale; mostly useful for risk-appetite context rather than operating likeness.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCAPRCapricor Therapeutics
INVA
Innoviva
CAPR
Capricor Therapeutics
Grade
C
B
Momentum
34
64
Value
71
41
Sentiment
63
67
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs CAPR

INVA / CAPR
Grade Position
In line
INVA vs. peer average (C vs. C)
47/100
Momentum
34
CAPR
Value
71
INVA
Sentiment
63
CAPR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INVA
1
CAPR
CAPR
B
80/100
-1
2
GILD
GILD
C
60/100
Even
3
INBX
INBX
D
40/100
+1
4
AMLX
Amylyx Pharmaceuticals Inc Common
D
40/100
+1
5
PVLA
Palvella Therapeutics Inc Common
C
60/100
Even
CAPR is the first peer returned for this comparison set.